The Therapeutic Strategies for SLE by Targeting Anti-dsDNA Antibodies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Therapeutic Strategies for SLE by Targeting Anti-dsDNA Antibodies
Authors
Keywords
-
Journal
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-20
DOI
10.1007/s12016-021-08898-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of the Migration of Distinct Dendritic Cell Subsets
- (2021) Meng Feng et al. Frontiers in Cell and Developmental Biology
- Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology
- (2020) Jasper C. A. Broen et al. Nature Reviews Rheumatology
- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
- (2020) Eva Schrezenmeier et al. Nature Reviews Rheumatology
- Meta-analysis on the efficacy and safety of immunoadsorption for systemic lupus erythematosus among Chinese population
- (2020) Meng Yang et al. CLINICAL RHEUMATOLOGY
- Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus
- (2020) Mariele Gatto et al. Arthritis & Rheumatology
- Systemic lupus erythematosus (SLE): emerging therapeutic targets.
- (2020) Lauren M Mathias et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- TWEAK/Fn14 axis is an important player in fibrosis
- (2020) Yitian Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
- (2020) Richard Furie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toll-like receptor signalling in B cells during systemic lupus erythematosus
- (2020) Simon Fillatreau et al. Nature Reviews Rheumatology
- The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?
- (2020) Marcello Govoni et al. RHEUMATOLOGY
- Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs
- (2020) Guillermo Ruiz-Irastorza et al. RHEUMATOLOGY
- B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)
- (2020) Tamara Möckel et al. AUTOIMMUNITY REVIEWS
- An updated advance of autoantibodies in autoimmune diseases
- (2020) Ze Xiu Xiao et al. AUTOIMMUNITY REVIEWS
- Neuropsychiatric lupus: new mechanistic insights and future treatment directions
- (2019) Noa Schwartz et al. Nature Reviews Rheumatology
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
- (2019) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab as maintenance treatment for systemic Lupus Erythematosus: a multicentre observational study of 147 patients
- (2019) Matthias A. Cassia et al. Arthritis & Rheumatology
- New therapies for systemic lupus erythematosus — past imperfect, future tense
- (2019) Grainne Murphy et al. Nature Reviews Rheumatology
- Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies
- (2019) Xiaoyu Wang et al. Frontiers in Immunology
- BAFF inhibition in SLE-Is tolerance restored?
- (2019) Shaun W Jackson et al. IMMUNOLOGICAL REVIEWS
- Genetic contributors and soluble mediators in prediction of autoimmune comorbidity
- (2019) Adrianos Nezos et al. JOURNAL OF AUTOIMMUNITY
- Towards a pro-resolving concept in systemic lupus erythematosus
- (2019) Sebastian Boeltz et al. Seminars in Immunopathology
- Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations
- (2019) Ignacio Sanz et al. Frontiers in Immunology
- Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion
- (2018) Mario Mauthe et al. Autophagy
- Recent developments in biologic therapies for the treatment of patients with systemic lupus erythematosus
- (2018) Pedro L Carreira et al. RHEUMATOLOGY
- Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus
- (2018) Joan T. Merrill et al. Arthritis & Rheumatology
- Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers
- (2018) Seyed Mostafa Monzavi et al. INFLAMMOPHARMACOLOGY
- Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial
- (2018) Joan T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- Indoleamine-2,3-dioxygenase in murine and human systemic lupus erythematosus: Down-regulation by the tolerogeneic peptide hCDR1
- (2018) Zev Sthoeger et al. CLINICAL IMMUNOLOGY
- Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus
- (2018) Scott A. Jenks et al. IMMUNITY
- The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting
- (2018) Laurie Baert et al. JOURNAL OF AUTOIMMUNITY
- Systemic lupus erythematosus: Diagnosis and clinical management
- (2018) Andrea Fava et al. JOURNAL OF AUTOIMMUNITY
- Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus
- (2018) Rita Quelhas da Costa et al. JAMA Dermatology
- The deposition of anti-DNA IgG contributes to the development of cutaneous lupus erythematosus
- (2017) Yingying Dong et al. IMMUNOLOGY LETTERS
- Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
- (2017) Venkat Reddy et al. RHEUMATOLOGY
- Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
- (2017) Eoghan M McCarthy et al. RHEUMATOLOGY
- Immunoadsorption for collagen and rheumatic diseases
- (2017) Ken Yamaji TRANSFUSION AND APHERESIS SCIENCE
- Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials
- (2017) Megan E. B. Clowse et al. Arthritis & Rheumatology
- TWEAK/Fn14 Activation Participates in Ro52-Mediated Photosensitization in Cutaneous Lupus Erythematosus
- (2017) Yale Liu et al. Frontiers in Immunology
- Transcriptomic profiling in human mesangial cells using patient-derived lupus autoantibodies identified miR-10a as a potential regulator of IL8
- (2017) Pattarin Tangtanatakul et al. Scientific Reports
- Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review
- (2016) Andreas Kronbichler et al. AUTOIMMUNITY REVIEWS
- The features of skin inflammation induced by lupus serum
- (2016) Lena Liu et al. CLINICAL IMMUNOLOGY
- Overview of pathophysiology and treatment of human lupus nephritis
- (2016) Kimberly Trotter et al. CURRENT OPINION IN RHEUMATOLOGY
- Amending HIV Drugs: A Novel Small-Molecule Approach To Target Lupus Anti-DNA Antibodies
- (2016) Sonya VanPatten et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLE
- (2016) Aparna Mahajan et al. Frontiers in Immunology
- Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) J T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- A peptide mimic blocks the cross-reaction of anti-DNA antibodies with glomerular antigens
- (2015) Y. Xia et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- DNA-histone complexes as ligands amplify cell penetration and nuclear targeting of anti-DNA antibodies via energy-independent mechanisms
- (2015) Markella Zannikou et al. IMMUNOLOGY
- Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus
- (2015) Juan P. Mackern-Oberti et al. IMMUNOLOGY
- Cutting Edge: Antimalarial Drugs Inhibit IFN-β Production through Blockade of Cyclic GMP-AMP Synthase–DNA Interaction
- (2015) Jie An et al. JOURNAL OF IMMUNOLOGY
- TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus
- (2015) Jessica L. Doerner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Anti-dsDNA antibodies induce inflammation via endoplasmic reticulum stress in human mesangial cells
- (2015) Hui Zhang et al. Journal of Translational Medicine
- Crosstalk between the cGAS DNA Sensor and Beclin-1 Autophagy Protein Shapes Innate Antimicrobial Immune Responses
- (2014) Qiming Liang et al. Cell Host & Microbe
- Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus
- (2014) William Stohl EXPERT OPINION ON THERAPEUTIC TARGETS
- Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus
- (2014) Zev Sthoeger et al. JOURNAL OF AUTOIMMUNITY
- pConsensus Peptide Induces Tolerogenic CD8+ T Cells in Lupus-Prone (NZB x NZW)F1 Mice by Differentially Regulating Foxp3 and PD1 Molecules
- (2014) R. P. Singh et al. JOURNAL OF IMMUNOLOGY
- Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes
- (2014) Menna R Clatworthy et al. NATURE MEDICINE
- Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double-Blind, Phase III Study
- (2013) Eduardo F. Mysler et al. ARTHRITIS AND RHEUMATISM
- Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis
- (2013) A. L. Rankin et al. JOURNAL OF IMMUNOLOGY
- Brutonˈs tyrosine kinase-an integral protein of B cell development that also has an essential role in the innate immune system
- (2013) Gabriela López-Herrera et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) – results from a nationwide cohort in Germany (GRAID)
- (2013) M Witt et al. LUPUS
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
- (2012) George K Bertsias et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice
- (2012) L. P. Kil et al. BLOOD
- Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis
- (2012) Yumin Xia et al. CLINICAL IMMUNOLOGY
- Noncanonical Autophagy Is Required for Type I Interferon Secretion in Response to DNA-Immune Complexes
- (2012) Jill Henault et al. IMMUNITY
- The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies
- (2012) Yumin Xia et al. JOURNAL OF AUTOIMMUNITY
- The DWEYS peptide in systemic lupus erythematosus
- (2012) Xavier Bosch et al. TRENDS IN MOLECULAR MEDICINE
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
- (2012) Bevra H. Hahn et al. ARTHRITIS CARE & RESEARCH
- Biologic Differences Between Various Inhibitors of the BLyS/BAFF Pathway: Should We Expect Differences Between Belimumab and Other Inhibitors in Development?
- (2012) William Stohl Current Rheumatology Reports
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice
- (2011) Chaim O. Jacob et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Oral administration of different forms of a tolerogenic peptide to define the preparations and doses that delay anti-DNA antibody production and nephritis and prolong survival in SLE-prone mice
- (2011) BJ Skaggs et al. LUPUS
- Gene expression of TWEAK/Fn14 and IP-10/CXCR3 in glomerulus and tubulointerstitium of patients with lupus nephritis
- (2011) JIANXIN LU et al. NEPHROLOGY
- Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity
- (2011) O. Bloom et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antigen-specific immature dendritic cell vaccine ameliorates anti-dsDNA antibody-induced renal damage in a mouse model
- (2011) Y. Xia et al. RHEUMATOLOGY
- Regulation of the B Cell Receptor Repertoire and Self-Reactivity by BAFF
- (2010) M. Ota et al. JOURNAL OF IMMUNOLOGY
- Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus
- (2010) B. Diamond et al. JOURNAL OF INTERNAL MEDICINE
- Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms
- (2010) T. W. Faust et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amelioration of brain pathology and behavioral dysfunction in mice with lupus following treatment with a tolerogenic peptide
- (2009) Smadar Lapter et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus
- (2009) Reshmi Parameswaran et al. CLINICAL IMMUNOLOGY
- TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells
- (2009) Hua-Xin Gao et al. CYTOKINE
- Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients
- (2008) Bevra H. Hahn et al. ARTHRITIS AND RHEUMATISM
- Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo-controlled, dose-ranging study
- (2008) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models
- (2008) Uri Sela et al. IMMUNOLOGY
- An antibody-based construct carrying DNA-mimotope and targeting CR1(CD35) selectively suppresses human autoreactive B-lymphocytes
- (2008) Elisaveta Voynova et al. IMMUNOLOGY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now